---
figid: PMC9182524__molecules-27-03412-g003
figtitle: Review of Twenty Years of Research on the Regulation of Signaling Pathways
  by Natural Products in Breast Cancer
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC9182524
filename: molecules-27-03412-g003.jpg
figlink: /pmc/articles/PMC9182524/figure/molecules-27-03412-f003/
number: F3
caption: 'The schematic representation of the PI3K/Akt/mTOR signaling pathway in BC.
  VEGF: vascular endothelial growth factor; NF-κB: nuclear factor kappa-B; EGF(R):
  epidermal growth factor (receptor); mTOR: mammalian target of rapamycin; PDK1/2:
  3-phosphoinositide-dependent kinase-1/2; PI3K: phosphatidylinositol 3-kinase; MMP:
  matrix metalloprotein; PIP-3: phosphatidylinositol (3,4,5)-trisphosphate; Bcl-2:
  B-cell lymphoma 2; mTORC-2: mTOR complex 2; VRGF: vascular endothelial growth factor;
  Bad: Bcl-2 antagonist of cell death. This figure is reproduced from Dong et al.
  [] (Creative Commons Attribution License (CC BY 4.0)).'
papertitle: A Review of Twenty Years of Research on the Regulation of Signaling Pathways
  by Natural Products in Breast Cancer.
reftext: Muhammad Naeem, et al. Molecules. 2022 Jun;27(11):3412.
year: '2022'
doi: 10.3390/molecules27113412
journal_title: Molecules
journal_nlm_ta: Molecules
publisher_name: MDPI
keywords: breast cancer | natural products | transcription factors | signaling pathways
  | treatment | therapeutic agents | combination therapy
automl_pathway: 0.9446853
figid_alias: PMC9182524__F3
figtype: Figure
redirect_from: /figures/PMC9182524__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9182524__molecules-27-03412-g003.html
  '@type': Dataset
  description: 'The schematic representation of the PI3K/Akt/mTOR signaling pathway
    in BC. VEGF: vascular endothelial growth factor; NF-κB: nuclear factor kappa-B;
    EGF(R): epidermal growth factor (receptor); mTOR: mammalian target of rapamycin;
    PDK1/2: 3-phosphoinositide-dependent kinase-1/2; PI3K: phosphatidylinositol 3-kinase;
    MMP: matrix metalloprotein; PIP-3: phosphatidylinositol (3,4,5)-trisphosphate;
    Bcl-2: B-cell lymphoma 2; mTORC-2: mTOR complex 2; VRGF: vascular endothelial
    growth factor; Bad: Bcl-2 antagonist of cell death. This figure is reproduced
    from Dong et al. [] (Creative Commons Attribution License (CC BY 4.0)).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Mtor
  - Tor
  - Tie
  - Ras85D
  - InR
  - ww
  - Myb
  - Taf5
  - Akt
  - Dif
  - dl
  - Rel
  - Mmp1
  - mid
  - Pten
  - Pgk
  - cass
  - Debcl
  - mama
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - AKT1
  - AKT2
  - AKT3
  - NFKB1
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - PTEN
  - PGK1
  - BAD
  - BCL2
---
